Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/17/2008
 
First Published:
1/24/2005
1.
Phase II Randomized Study of Adjuvant Vaccine Therapy Comprising Vaccinia-CEA-MUC-1-TRICOM Vaccine (PANVAC-V) and Fowlpox-CEA-MUC-1-TRICOM Vaccine (PANVAC-F) Administered With Autologous Dendritic Cells or Sargramostim (GM-CSF) in Patients With Completely Resected Hepatic Metastases Secondary to Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
DUMC-5883-04-6RO
NCT00103142
Last Modified:
8/25/2008
 
First Published:
9/16/2005
2.
Phase II Randomized Pilot Study of Docetaxel With Versus Without Vaccinia-CEA-MUC-1-TRICOM Vaccine, Fowlpox-CEA-MUC-1-TRICOM Vaccine, and Sargramostim (GM-CSF) in Patients With Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
NCI-05-C-0229
6977, NCI-6977, NCT00217750
First Published:
4/28/2008
3.
Phase I Study of Intratumoral Recombinant Fowlpox PANVAC Vaccine (PANVAC-F; Falimarev) and Subcutaneous Recombinant Vaccinia PANVAC Vaccine (PANVAC-V; Inalimarev) Followed by Subcutaneous PANVAC-F Vaccine and Sargramostim (GM-CSF) in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Approved-not yet active
Over 18
NCI
CINJ-070602
070602, 7606, CINJ-IRB-0220060270, NCT00669734
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute